Tracey Cristine Fleischer

Title: Tracey Cristine Fleischer: Innovator in Predictive Biomarkers

Introduction

Tracey Cristine Fleischer is a prominent inventor based in Sandy, UT (US). She has made significant contributions to the field of predictive biomarkers, particularly in relation to pregnancy and preterm birth. With a total of 6 patents, her work is paving the way for advancements in maternal health.

Latest Patents

Fleischer's latest patents include groundbreaking innovations such as "Biomarker pairs for predicting preterm birth." This patent discloses a pair of isolated biomarkers that can predict the risk of preterm birth by measuring changes in reversal values between pregnant females at risk and term controls. Another notable patent is "Pregnancy clock proteins for predicting due date and time to birth," which offers methods for predicting due dates with significantly higher accuracy than current clinical methods. These innovations have the potential to transform prenatal care and improve outcomes for mothers and infants.

Career Highlights

Throughout her career, Fleischer has worked with notable organizations such as Sera Prognostics, Inc. and the Alzheimer's Institute of America, Inc. Her experience in these companies has allowed her to collaborate with leading experts in the field and contribute to significant research initiatives.

Collaborations

Fleischer has collaborated with professionals like Andrew Gassman and John Jay Boniface, further enhancing her research and development efforts in the field of predictive biomarkers.

Conclusion

Tracey Cristine Fleischer's innovative work in predictive biomarkers is making a substantial impact on maternal health. Her patents and collaborations reflect her commitment to advancing medical science and improving the lives of pregnant women and their children.